PA
EW icon

Pineridge Advisors’s Edwards Lifesciences EW Stock Holding History

Pineridge Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-51
Closed -$3.99K – 495
2025
Q2 		$3.99K Hold
51
– – ﹤0.01% 339
2025
Q1 		$3.7K Buy
51
+45
+750% +$3.22K ﹤0.01% 349
2024
Q4 		$444 Hold
6
– – ﹤0.01% 576
2024
Q3 		$396 Hold
6
– – ﹤0.01% 546
2024
Q2 		$554 Hold
6
– – ﹤0.01% 569
2024
Q1 		$573 Hold
6
– – ﹤0.01% 553
2023
Q4 		$458 Buy
+6
New +$417 ﹤0.01% 746

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Pineridge Advisors's EW Position: Q3 2025 in Review

Pineridge Advisors sold out of Edwards Lifesciences (EW) in Q3 2025, closing a stake of 51 shares — an estimated $3.99K sold.

Pineridge Advisors first reported a position in EW in Q4 2023 and held it in 7 quarters. The position peaked at $3.99K in Q2 2025. 1,253 funds tracked by Wall St. Rank hold EW as of Q3 2025.

  • Pineridge Advisors reported no remaining Edwards Lifesciences position as of Q3 2025 after selling out during the quarter.
  • Pineridge Advisors sold 51 Edwards Lifesciences shares in Q3 2025, an estimated $3.99K.
  • Pineridge Advisors first reported a position in Edwards Lifesciences in Q4 2023 and held it in 7 quarters.
  • Pineridge Advisors's Edwards Lifesciences position peaked at $3.99K in Q2 2025.
  • 1,253 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on Pineridge Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.